Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial
Jordana B. Cohen(University of Pennsylvania), Julio A. Chirinos(The Lundquist Institute), Daniel Edmonston(Duke University), Alejandro Barbagelata(Favaloro Foundation), C. Medina(Hospital Nacional Cayetano Heredia), Luis E Bendezú-Huasasquiche, Tara I. Chang, Luz Alicia González-Hernández(Hospital Civil de Guadalajara), Tiffany Sharkoski(Hospital of the University of Pennsylvania), Preethi William(University of Arizona), Nelson R. Rosado‐Santander(Hospital Nacional Cayetano Heredia), Renzo Valdivia-Vega(Hospital Nacional Cayetano Heredia), Carlos Augusto Castro‐Callirgos(Instituto Nacional de Salud del Niño), Jaime Andrade‐Villanueva(Hospital Civil de Guadalajara), Jesse Chittams, Nicolás Renna(University of Mendoza), Eduardo F Bernales-Salas(Hospital Nacional Cayetano Heredia), James Brian Byrd(University of Michigan), Juan E. Rodriguez‐Mori(Instituto Nacional de Salud del Niño), Roberto Cristodulo-Cortez(Universidad Privada de Santa Cruz de la Sierra), Cynthia Daniela Salinas Herrera(Hospital Nacional Cayetano Heredia), Omar A Díaz-Cucho, Jonas Spaak(Karolinska University Hospital), Johanna C Coacalla-Guerra(Hospital Nacional Cayetano Heredia), Nancy K. Sweitzer(National Heart Lung and Blood Institute), Vicente Corrales‐Medina(University of Ottawa), Mauro Basconcel, Ricardo Ayala(Hospital Nacional Cayetano Heredia), Carlos E. Alfonso(University of Miami), Liliana Nicolosi, Thomas C. Hanff(University of Pennsylvania), Charles R. Vasquez(Hospital of the University of Pennsylvania), Mirko Villavicencio-Carranza(Hospital Nacional Cayetano Heredia)
Cited by 224
Related Papers
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
|Circulation|2019|1.3k
Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial
|Circulation|2014|1k
Chronic Kidney Disease and Coronary Artery Disease
|Journal of the American College of Cardiology|2019|716
Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction
|Journal of the American College of Cardiology|1999|541